These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 8389122
1. Down-regulated beta-adrenoceptors in severely failing human ventricles: uniform regional distribution, but no increased internalization. Pitschner HF, Droege A, Mitze M, Schlepper M, Brodde OE. Basic Res Cardiol; 1993; 88(2):179-91. PubMed ID: 8389122 [Abstract] [Full Text] [Related]
2. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. Brodde OE, Vogelsang M, Broede A, Michel-Reher M, Beisenbusch-Schäfer E, Hakim K, Zerkowski HR. J Cardiovasc Pharmacol; 1998 Apr; 31(4):585-94. PubMed ID: 9554809 [Abstract] [Full Text] [Related]
3. Regional distribution of beta 1- and beta 2-adrenoceptors in the failing and nonfailing human heart. Steinfath M, Lavicky J, Schmitz W, Scholz H, Döring V, Kalmár P. Eur J Clin Pharmacol; 1992 Apr; 42(6):607-11. PubMed ID: 1320570 [Abstract] [Full Text] [Related]
4. Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. Brodde OE, Schüler S, Kretsch R, Brinkmann M, Borst HG, Hetzer R, Reidemeister JC, Warnecke H, Zerkowski HR. J Cardiovasc Pharmacol; 1986 Apr; 8(6):1235-42. PubMed ID: 2434752 [Abstract] [Full Text] [Related]
5. Autoradiographic localization and quantitation of beta 1- and beta 2-adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. Elnatan J, Molenaar P, Rosenfeldt FL, Summers RJ. J Mol Cell Cardiol; 1994 Mar; 26(3):313-23. PubMed ID: 7913135 [Abstract] [Full Text] [Related]
6. Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. Böhm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, Schmitz W, Schnabel P, Scholz H, Steinfath M. J Mol Cell Cardiol; 1994 Feb; 26(2):133-49. PubMed ID: 8006975 [Abstract] [Full Text] [Related]
7. Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts. Beau SL, Tolley TK, Saffitz JE. Circulation; 1993 Dec; 88(6):2501-9. PubMed ID: 7902783 [Abstract] [Full Text] [Related]
8. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL. Circulation; 2001 Mar 27; 103(12):1649-55. PubMed ID: 11273992 [Abstract] [Full Text] [Related]
9. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Steinfath M, Danielsen W, von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H. Br J Pharmacol; 1992 Feb 27; 105(2):463-9. PubMed ID: 1348446 [Abstract] [Full Text] [Related]
10. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J. Circulation; 1991 Sep 27; 84(3):1024-39. PubMed ID: 1653120 [Abstract] [Full Text] [Related]
11. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy. Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M. J Heart Lung Transplant; 2008 Jul 27; 27(7):767-74. PubMed ID: 18582807 [Abstract] [Full Text] [Related]
12. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abraham WT, Raynolds MV, Zisman LS, Perryman MB, Bristow MR. Circulation; 1997 Mar 04; 95(5):1193-200. PubMed ID: 9054849 [Abstract] [Full Text] [Related]
13. Myocardial beta-adrenoceptors and inhibitory G-proteins in myocardial biopsies and in explanted hearts from patients with dilated cardiomyopathy. Böhm M, Gierschik P, Schnabel P, Erdmann E. Cardioscience; 1990 Jun 04; 1(2):109-17. PubMed ID: 1966374 [Abstract] [Full Text] [Related]
14. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue. Roselló-Lletí E, Alonso J, Cortés R, Almenar L, Martínez-Dolz L, Sánchez-Lázaro I, Lago F, Azorín I, Juanatey JR, Portolés M, Rivera M. J Cell Mol Med; 2012 Oct 04; 16(10):2471-86. PubMed ID: 22435364 [Abstract] [Full Text] [Related]
15. Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Schwinger RH, Böhm M, Erdmann E. Am Heart J; 1990 Apr 04; 119(4):899-904. PubMed ID: 1969707 [Abstract] [Full Text] [Related]
16. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV. J Clin Invest; 1992 Mar 04; 89(3):803-15. PubMed ID: 1311717 [Abstract] [Full Text] [Related]
17. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Koumi S, Backer CL, Arentzen CE. Circulation; 1995 Jul 15; 92(2):164-74. PubMed ID: 7600647 [Abstract] [Full Text] [Related]
18. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism. Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ. Clin Exp Pharmacol Physiol; 2007 Oct 15; 34(10):1020-8. PubMed ID: 17714089 [Abstract] [Full Text] [Related]
19. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation. Böhm M, Diet F, Feiler G, Kemkes B, Kreuzer E, Weinhold C, Erdmann E. J Cardiovasc Pharmacol; 1988 Dec 15; 12(6):726-32. PubMed ID: 2467092 [Abstract] [Full Text] [Related]